Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Regional scope
1.1.2. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Industry Dynamics, Trends and Scope
2.1. Industry Dynamics
2.1.1. Industry driver analysis
2.1.2. Industry restraint analysis
2.1.3. Industry opportunity analysis
2.1.4. Industry challenge analysis
2.2. Industry Analysis Tools
2.2.1. Industry Analysis - Porter’s
2.2.1.1. Bargaining power of suppliers
2.2.1.2. Bargaining power of buyers
2.2.1.3. Threat of substitutes
2.2.1.4. Threat of new entrants
2.2.1.5. Competitive rivalry
2.2.2. PESTEL Analysis
2.2.2.1. Political & Legal Landscape
2.2.2.2. Economic and Social Landscape
2.2.2.3. Technological landscape
Chapter 3. Competitive Landscape
3.1. Recent Developments & Impact Analysis, By Key Market Participants
3.2. Company/Competition Categorization
3.2.1. Innovators
3.3. Vendor Landscape
3.3.1. List of key distributors and channel partners
3.3.2. Global Key company market share analysis, 2024
3.3.2.1. GT Medical Technologies, Inc.
3.3.2.1.1. Company overview
3.3.2.1.2. Financial performance
3.3.2.1.3. Product benchmarking
3.3.2.1.4. Strategic initiatives
3.3.2.2. Novocure
3.3.2.2.1. Company overview
3.3.2.2.2. Financial performance
3.3.2.2.3. Product benchmarking
3.3.2.2.4. Strategic initiatives
3.3.2.3. ZAP Surgical Systems, Inc.
3.3.2.3.1. Company overview
3.3.2.3.2. Financial performance
3.3.2.3.3. Product benchmarking
3.3.2.3.4. Strategic initiatives
3.3.2.4. Aesculap, Inc. - a B. Braun company
3.3.2.4.1. Company overview
3.3.2.4.2. Financial performance
3.3.2.4.3. Product benchmarking
3.3.2.4.4. Strategic initiatives
3.3.2.5. Accuray Incorporated
3.3.2.5.1. Company overview
3.3.2.5.2. Financial performance
3.3.2.5.3. Product benchmarking
3.3.2.5.4. Strategic initiatives
3.3.2.6. Carthera
3.3.2.6.1. Company overview
3.3.2.6.2. Financial performance
3.3.2.6.3. Product benchmarking
3.3.2.6.4. Strategic initiatives
3.3.2.7. Alpheus Medical Inc.
3.3.2.7.1. Company overview
3.3.2.7.2. Financial performance
3.3.2.7.3. Product benchmarking
3.3.2.7.4. Strategic initiatives
3.3.2.8. Alpha Tau Medical Ltd
3.3.2.8.1. Company overview
3.3.2.8.2. Financial performance
3.3.2.8.3. Product benchmarking
3.3.2.8.4. Strategic initiatives
3.3.2.9. Elekta
3.3.2.9.1. Company overview
3.3.2.9.2. Financial performance
3.3.2.9.3. Product benchmarking
3.3.2.9.4. Strategic initiatives
3.3.2.10. IMRIS Inc.
3.3.2.10.1. Company overview
3.3.2.10.2. Financial performance
3.3.2.10.3. Product benchmarking
3.3.2.10.4. Strategic initiatives
3.3.2.11. Medtronic
3.3.2.11.1. Company overview
3.3.2.11.2. Financial performance
3.3.2.11.3. Product benchmarking
3.3.2.11.4. Strategic initiatives
3.3.2.12. Monteris
3.3.2.12.1. Company overview
3.3.2.12.2. Financial performance
3.3.2.12.3. Product benchmarking
3.3.2.12.4. Strategic initiatives
3.3.2.13. Openwater
3.3.2.13.1. Company overview
3.3.2.13.2. Financial performance
3.3.2.13.3. Product benchmarking
3.3.2.13.4. Strategic initiatives
3.3.2.14. Acoustic MedSystems, Inc.
3.3.2.14.1. Company overview
3.3.2.14.2. Financial performance
3.3.2.14.3. Product benchmarking
3.3.2.14.4. Strategic initiatives
3.3.2.15. NaviFUS Corp
3.3.2.15.1. Company overview
3.3.2.15.2. Financial performance
3.3.2.15.3. Product benchmarking
3.3.2.15.4. Strategic initiatives
3.3.2.16. Insightec
3.3.2.16.1. Company overview
3.3.2.16.2. Financial performance
3.3.2.16.3. Product benchmarking
3.3.2.16.4. Strategic initiatives
3.3.2.17. Varian Medical Systems, Inc. (Siemens Healthineers)
3.3.2.17.1. Company overview
3.3.2.17.2. Financial performance
3.3.2.17.3. Product benchmarking
3.3.2.17.4. Strategic initiatives
3.3.2.18. RefleXion
3.3.2.18.1. Company overview
3.3.2.18.2. Financial performance
3.3.2.18.3. Product benchmarking
3.3.2.18.4. Strategic initiatives
3.3.2.19. MagnetTx Oncology Solutions Ltd.
3.3.2.19.1. Company overview
3.3.2.19.2. Financial performance
3.3.2.19.3. Product benchmarking
3.3.2.19.4. Strategic initiatives
3.3.2.20. NICO Corporation (Stryker)
3.3.2.20.1. Company overview
3.3.2.20.2. Financial performance
3.3.2.20.3. Product benchmarking
3.3.2.20.4. Strategic initiatives
3.3.2.21. Terumo Interventional Systems
3.3.2.21.1. Company overview
3.3.2.21.2. Financial performance
3.3.2.21.3. Product benchmarking
3.3.2.21.4. Strategic initiatives
3.3.2.22. Boston Scientific Corporation
3.3.2.22.1. Company overview
3.3.2.22.2. Financial performance
3.3.2.22.3. Product benchmarking
3.3.2.22.4. Strategic initiatives
3.3.2.23. Koninklijke Philips N.V.
3.3.2.23.1. Company overview
3.3.2.23.2. Financial performance
3.3.2.23.3. Product benchmarking
3.3.2.23.4. Strategic initiatives
3.3.2.24. IBA Worldwide
3.3.2.24.1. Company overview
3.3.2.24.2. Financial performance
3.3.2.24.3. Product benchmarking
3.3.2.24.4. Strategic initiatives